The Motley Fool

Here’s why I just bought Dr Martens shares

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Concentrated young african american black guy sitting on heated floor at modern coffee table in living room, looking at laptop screen
Image source: Getty Images

Back in February, I wrote an article explaining why I thought Dr Martens (LSE: DOCS) shares were a buy for my portfolio. Recently, the company released its earnings results for fiscal year 2021. Investors initially reacted negatively to the news sending the share price down 17%. In the last few days, the share price has risen 7% but remains 11% below its pre-earnings share price. What happened and why am I now jumping in?

The results

Despite the drop in the share price, the company performed well last year. During FY21, Dr Martens managed to sell 12.7m pairs of boots, up from 11.1m pairs the year before. It also grew revenues by 15% and expanded margins, with EBITDA (earnings before interest, tax, depreciation and amortisation) growing by 22%.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

While retail sales fell 40% due to the effects of the pandemic, the company had huge success in its e-commerce business, which grew 73% year-on-year. At the end of the year, e-commerce contributed 30% of the company’s revenues.

Why did the shares fall?

In my opinion, Dr Martens shares tumbled because investors were disappointed by the guidance that was issued. Management reiterated the guidance given when the company first went public at the beginning of the year. Revenue growth should be a high-teens percentage next year and in the mid-teens over the medium term. This growth represents a steep decline from the 48% the company achieved in FY20 and is likely why many investors sold their shares following the news.

These disappointed investors may have a point. If the growth rate can fall that quickly, what’s to stop it falling further in the coming years? Despite these doubts, I still feel confident that the company can achieve its targets in the future.

Why did I buy Dr Martens shares?

As I wrote in my first article, I think Dr Martens is a great business. The company is growing revenues at a quick pace and it has a very strong brand that makes it difficult to compete with. I also think the company is likely to expand its margins as its direct-to-consumer (DTC) business becomes more important. Currently, DTC represents 40% of total revenues. Management is targeting this figure to reach 60% in the medium term.

The recent pullback in the share price also means that the shares are trading at an attractive valuation for me. At the time of writing, the share price stands at 439p. At this price, the company’s price-to-operating-income ratio stands at 39, which initially seems very high. However, when the exceptional costs of the IPO (initial public offering) are removed, this ratio falls to 23. As these costs will not occur again next year, I prefer to use the second figure. Using this ratio, the share price seems attractive considering the expected growth rate and quality of the business. For this reason, I decided to add Dr Martens shares to my portfolio.

FREE REPORT: Why this £5 stock could be set to surge

Are you on the lookout for UK growth stocks?

If so, get this FREE no-strings report now.

While it’s available: you'll discover what we think is a top growth stock for the decade ahead.

And the performance of this company really is stunning.

In 2019, it returned £150million to shareholders through buybacks and dividends.

We believe its financial position is about as solid as anything we’ve seen.

  • Since 2016, annual revenues increased 31%
  • In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259
  • Operating cash flow is up 47%. (Even its operating margins are rising every year!)

Quite simply, we believe it’s a fantastic Foolish growth pick.

What’s more, it deserves your attention today.

So please don’t wait another moment.

Get the full details on this £5 stock now – while your report is free.

Ollie Henry owns shares in Dr Martens. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.